...
首页> 外文期刊>BMC Pediatrics >Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: A randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048]
【24h】

Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: A randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048]

机译:干酪乳杆菌GG菌株在婴儿急性水泻中的治疗:一项随机,双盲,安慰剂对照的临床试验[ISRCTN67363048]

获取原文

摘要

Background Adjuvant therapy to ORT with probiotic bacteria for infants with acute watery diarrhea has been under active investigation. Most studies have been done in the developed world showing benefit only for viral mild gastroenteritis. We evaluated the effect of a milk formula containing one billion (109) cfu/ml of Lactobacillus casei strain GG (LGG) upon duration and severity of diarrhea in infants in an environment with more severe acute diarrhea, where etiologic agents other than rotavirus are involved more frequently, and where mixed infections are more prevalent. Methods Male infants aged 3–36 months brought for treatment of acute watery diarrhea of less than 48 hours were eligible. After rehydration was completed with the WHO's oral rehydration solution, patients were randomly assigned to receive a milk formula either containing LGG or not. Stool volume was periodically measured using a devise suited to collect stools separate from urine. Duration of diarrhea was estimated based on stools physical characteristics. Results Eighty nine patients received the placebo milk formula and ninety received the LGG containing formula. Both groups were comparable in their baseline characteristics. Total stool output was significantly larger (p = 0.047) in the LGG group (247.8 ml/kg) than in the placebo group (195.0 ml/kg). No significant differences were found in duration of diarrhea (58.5 hours with LGG vs. 50.4 hours with placebo), rate of treatment failure (21.1% with LGG vs. 18.0% with placebo), and proportion of patients with unresolved diarrhea after 120 hours (12.2% with LGG vs. 12.5% with placebo). The rate of stools with reducing substances after 24 hours of treatment increased significantly in both groups (from 41.4% to 72.2% with LGG and from 45.9% to 68.0% with placebo). Conclusion This study did not show a positive effect of LGG on the clinical course of acute watery diarrhea. Positive beneficial effects of LGG, as had been reported elsewhere, could have been masked in our study by worsening diarrhea due to transient lactose malabsorption. Further studies with low-lactose or non-lactose conveyors of LGG are desirable.
机译:背景技术对患有急性水泻的婴儿进行益生菌对ORT的辅助治疗已在积极研究中。在发达国家,大多数研究表明仅对病毒性轻度胃肠炎有益。我们评估了在急性腹泻更为严重的环境中,含有10亿(10 9 )cfu / ml干酪乳杆菌GG(LGG)的牛奶配方对婴儿腹泻的持续时间和严重程度的影响,轮状病毒以外的病原体更常见,混合感染更为普遍。方法接受治疗少于48小时的急性水样腹泻的3–36个月的男婴符合条件。用WHO的口服补液完成补液后,患者被随机分配接受含LGG或不含LGG的配方奶。使用适合收集粪便和尿液的装置定期测量粪便量。根据大便的物理特征估计腹泻的持续时间。结果89例患者接受了安慰剂奶粉,其中90例接受了含LGG的奶粉。两组的基线特征相当。 LGG组(247.8 ml / kg)的总粪便输出量显着大于安慰剂组(195.0 ml / kg)(p = 0.047)。腹泻持续时间(LGG为58.5小时,安慰剂为50.4小时),治疗失败率(LGG为21.1%,安慰剂为18.0%)以及120小时后未解决的腹泻患者比例无明显差异( LGG占12.2%,安慰剂占12.5%)。两组在治疗24小时后使用还原性物质的粪便比率均显着增加(LGG从41.4%增加到72.2%,安慰剂从45.9%增加到68.0%)。结论LGG对急性水样腹泻的临床进程没有积极作用。正如其他地方所报道的那样,LGG的积极有益作用在我们的研究中可能被暂时性乳糖吸收不良所致的腹泻恶化所掩盖。希望用低乳糖或非乳糖的LGG输送机进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号